

SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.


Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.

A crop duster sprays fields near Pullman, Washington with pesticide.
"If the agency is going to allow such chemicals to be freely sold at Home Depot, Walmart, and farm supply stores, the very least the EPA must do is require a clear cancer warning on the label," said one critic.
The US Environmental Protection Agency has repeatedly failed to warn consumers of the cancer risks posed by pesticides—even when its own research has found those products to be carcinogenic, a pair of green groups said Monday.
The Center for Food Safety studied the EPA's permitted risk level in active components of both currently approved and legacy pesticides. CFS researchers found that the EPA allowed pesticides with a cancer risk "as high as 1 in every 100 people exposed, a far greater level than the EPA’s benchmark of a 1-in-a-million chance of developing cancer."
"Of the 570 unique pesticide chemicals that EPA’s Office of Pesticide program has classified for carcinogenic potential since 1985, over one-third (200, or 35%) are either possible human carcinogens (127) or likely to be carcinogenic to humans (73)," the CFS report notes. "The status of 62 others (11%) is uncertain, because EPA lacks sufficient data to make a determination.
A second report, from the Center for Biological Diversity (CBD), shows that of the 200 pesticides that are possible or likely human carcinogens, 125 are still registered for use.
CBD analyzed the labels of every pesticide currently approved by the EPA and found that the agency has placed cancer warnings on just 69 of 4,919 pesticide labels (1.4%) "containing an active ingredient that the agency has designated a 'likely' human carcinogen." Additionally, the EPA has put cancer warnings on just 242 of the 22,147 pesticide labels (1.1%) that "contain an ingredient the agency has designated as a 'possible' human carcinogen."
CFS science director Bill Freeses said in a statement Monday: “It’s bad enough that the EPA approves cancer-causing pesticides. But if the agency is going to allow such chemicals to be freely sold at Home Depot, Walmart, and farm supply stores, the very least the EPA must do is require a clear cancer warning on the label. Warnings save lives by incentivizing users to wear protective equipment that reduces risk."
Lori Ann Burd, director of environmental health at the CBD, said on Monday that “it's dumbfounding that the EPA has failed to require any cancer warning on thousands of pesticide products sold to the public that the agency itself has linked to cancer."
“Why should anyone have confidence in the EPA’s ability to keep tabs on the pesticide industry and protect us all from harmful poisons when it won’t even compel companies to put long-term health warnings on pesticides it knows are really dangerous?" she added.
Last month, CFS, CBD, and others denounced the EPA's reapproval of the pesticide dicamba—which scientific studies have linked to increased risk of cancer and hypothyroidism in high-dose exposure—for certain cotton and soybean crops.
The new CFS and CBD analyses come ahead of next month's oral arguments in Monsanto Company v. John L. Durnell, a case before the US Supreme Court in which Bayer, the Germany-based pharma giant that bought Monsanto in 2018, is seeking substantial immunity from future lawsuits filed by people in the United States who used glyphosate-based products like Roundup weedkiller and were then diagnosed with rare pesticide-linked cancers. The company has paid out billions of dollars to settle such suits.
CBD and other advocacy groups have also warned that the industry-backed Farm Bill currently advancing in the Republican-controlled Congress weakens or delays pesticide safety regulation, preempts state-level cancer warning rules, and shields chemical companies from lawsuits.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
The US Environmental Protection Agency has repeatedly failed to warn consumers of the cancer risks posed by pesticides—even when its own research has found those products to be carcinogenic, a pair of green groups said Monday.
The Center for Food Safety studied the EPA's permitted risk level in active components of both currently approved and legacy pesticides. CFS researchers found that the EPA allowed pesticides with a cancer risk "as high as 1 in every 100 people exposed, a far greater level than the EPA’s benchmark of a 1-in-a-million chance of developing cancer."
"Of the 570 unique pesticide chemicals that EPA’s Office of Pesticide program has classified for carcinogenic potential since 1985, over one-third (200, or 35%) are either possible human carcinogens (127) or likely to be carcinogenic to humans (73)," the CFS report notes. "The status of 62 others (11%) is uncertain, because EPA lacks sufficient data to make a determination.
A second report, from the Center for Biological Diversity (CBD), shows that of the 200 pesticides that are possible or likely human carcinogens, 125 are still registered for use.
CBD analyzed the labels of every pesticide currently approved by the EPA and found that the agency has placed cancer warnings on just 69 of 4,919 pesticide labels (1.4%) "containing an active ingredient that the agency has designated a 'likely' human carcinogen." Additionally, the EPA has put cancer warnings on just 242 of the 22,147 pesticide labels (1.1%) that "contain an ingredient the agency has designated as a 'possible' human carcinogen."
CFS science director Bill Freeses said in a statement Monday: “It’s bad enough that the EPA approves cancer-causing pesticides. But if the agency is going to allow such chemicals to be freely sold at Home Depot, Walmart, and farm supply stores, the very least the EPA must do is require a clear cancer warning on the label. Warnings save lives by incentivizing users to wear protective equipment that reduces risk."
Lori Ann Burd, director of environmental health at the CBD, said on Monday that “it's dumbfounding that the EPA has failed to require any cancer warning on thousands of pesticide products sold to the public that the agency itself has linked to cancer."
“Why should anyone have confidence in the EPA’s ability to keep tabs on the pesticide industry and protect us all from harmful poisons when it won’t even compel companies to put long-term health warnings on pesticides it knows are really dangerous?" she added.
Last month, CFS, CBD, and others denounced the EPA's reapproval of the pesticide dicamba—which scientific studies have linked to increased risk of cancer and hypothyroidism in high-dose exposure—for certain cotton and soybean crops.
The new CFS and CBD analyses come ahead of next month's oral arguments in Monsanto Company v. John L. Durnell, a case before the US Supreme Court in which Bayer, the Germany-based pharma giant that bought Monsanto in 2018, is seeking substantial immunity from future lawsuits filed by people in the United States who used glyphosate-based products like Roundup weedkiller and were then diagnosed with rare pesticide-linked cancers. The company has paid out billions of dollars to settle such suits.
CBD and other advocacy groups have also warned that the industry-backed Farm Bill currently advancing in the Republican-controlled Congress weakens or delays pesticide safety regulation, preempts state-level cancer warning rules, and shields chemical companies from lawsuits.
The US Environmental Protection Agency has repeatedly failed to warn consumers of the cancer risks posed by pesticides—even when its own research has found those products to be carcinogenic, a pair of green groups said Monday.
The Center for Food Safety studied the EPA's permitted risk level in active components of both currently approved and legacy pesticides. CFS researchers found that the EPA allowed pesticides with a cancer risk "as high as 1 in every 100 people exposed, a far greater level than the EPA’s benchmark of a 1-in-a-million chance of developing cancer."
"Of the 570 unique pesticide chemicals that EPA’s Office of Pesticide program has classified for carcinogenic potential since 1985, over one-third (200, or 35%) are either possible human carcinogens (127) or likely to be carcinogenic to humans (73)," the CFS report notes. "The status of 62 others (11%) is uncertain, because EPA lacks sufficient data to make a determination.
A second report, from the Center for Biological Diversity (CBD), shows that of the 200 pesticides that are possible or likely human carcinogens, 125 are still registered for use.
CBD analyzed the labels of every pesticide currently approved by the EPA and found that the agency has placed cancer warnings on just 69 of 4,919 pesticide labels (1.4%) "containing an active ingredient that the agency has designated a 'likely' human carcinogen." Additionally, the EPA has put cancer warnings on just 242 of the 22,147 pesticide labels (1.1%) that "contain an ingredient the agency has designated as a 'possible' human carcinogen."
CFS science director Bill Freeses said in a statement Monday: “It’s bad enough that the EPA approves cancer-causing pesticides. But if the agency is going to allow such chemicals to be freely sold at Home Depot, Walmart, and farm supply stores, the very least the EPA must do is require a clear cancer warning on the label. Warnings save lives by incentivizing users to wear protective equipment that reduces risk."
Lori Ann Burd, director of environmental health at the CBD, said on Monday that “it's dumbfounding that the EPA has failed to require any cancer warning on thousands of pesticide products sold to the public that the agency itself has linked to cancer."
“Why should anyone have confidence in the EPA’s ability to keep tabs on the pesticide industry and protect us all from harmful poisons when it won’t even compel companies to put long-term health warnings on pesticides it knows are really dangerous?" she added.
Last month, CFS, CBD, and others denounced the EPA's reapproval of the pesticide dicamba—which scientific studies have linked to increased risk of cancer and hypothyroidism in high-dose exposure—for certain cotton and soybean crops.
The new CFS and CBD analyses come ahead of next month's oral arguments in Monsanto Company v. John L. Durnell, a case before the US Supreme Court in which Bayer, the Germany-based pharma giant that bought Monsanto in 2018, is seeking substantial immunity from future lawsuits filed by people in the United States who used glyphosate-based products like Roundup weedkiller and were then diagnosed with rare pesticide-linked cancers. The company has paid out billions of dollars to settle such suits.
CBD and other advocacy groups have also warned that the industry-backed Farm Bill currently advancing in the Republican-controlled Congress weakens or delays pesticide safety regulation, preempts state-level cancer warning rules, and shields chemical companies from lawsuits.